Further, IF staining confirmed that acGM-1.8 treatment suppressed the secretion of IL-10 and VEGF-A and stimulated that of IFN-γ in the tumor tissue (Supplementary Fig. 11 e and f). This evidence concerns the gene VEGFA and neoplasm.